Skip to content

Effects of exercise for chronic kidney patients during hemodialysis.

Effects of a combined intradiiality exercise program in patients with chronic renal disease: randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4xqpmm
Enrollment
Unknown
Registered
2020-02-26
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Training program with associated exercises, aerobic training, resistance training and respiratory muscle training, intradialitic. Each exercise will be done on different days of the week, three times,
Behavioural
E02.779.474
E02.760.169.063.500.387.250

Sponsors

Universidade Federal do Triângulo Mineiro
Lead Sponsor
Universidade Federal do Triângulo Mineiro
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion: age over 18 years; due to the ease of travel and use of the consent form; being more than three months on hemodialysis, due to treatment adaptations; does not present any type of motor impairment that makes it impossible to evaluate and perform the exercise protocol, for patient and researcher safety. The conditions will be submitted to the medical staff of the renal replacement therapy unit; do not use medical contraindications for physical exercise; cognitive ability to understand the research process and sign the consent form; willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Exclusion: Known unstable medical condition (angina, uncontrolled hypertension, congestive heart failure, arrhythmogenic heart disease); Neuromuscular disorders (myasthenia gravis, amyotrophic lateral sclerosis, congenital muscular dystrophies, cerebellar ataxias); Pacemaker carriers; Stop voluntarily participating in the study; Do not perform exercise sessions for two consecutive weeks; Discharge or abandon treatment; Not being collaborative in the proposed evaluations.

Design outcomes

Primary

MeasureTime frame
Expected Outcome 1: produce positive effects on anthropometry, body composition, body mass index (BMI), waist circumference (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP), through measurement before and after intervention and analysis statistics, (it is intended to obtain a statistically significant reduction in the parameters analyzed).;Expected outcome 2: produce positive effects on biochemical variables: lactate, triglycerides and HDL-c cholesterol, LDL-c, glycated hemoglobin (HBA1C), inflammatory markers (reduction of pro-inflammatory cytokines IL-1b, IL-6, IL-8 , TNF-a and increased anti-inflammatory cytokines IL-10), these parameters will be analyzed from laboratory tests and compared statistically.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactPriscila Barbosa

Universidade Federal do Triângulo Mineiro

prilucasbarbosa@yahoo.com.br+553491112564

Outcome results

None listed

Source: REBEC (via WHO ICTRP)